Our Pricing

Lansoprazole vs Omeprazole for Acid Reflux

When comparing lansoprazole vs omeprazole UK options, both medications are proton pump inhibitors (PPIs) that effectively reduce stomach acid production to treat acid reflux, gastro-oesophageal reflux disease (GORD), and peptic ulcers. At Cured Pharmacy, our UK-registered clinical team can assess which PPI suits your symptoms, with transparent pricing from £9.99 and discreet next-day delivery across the UK.

How Lansoprazole and Omeprazole Work

Both lansoprazole and omeprazole belong to the proton pump inhibitor (PPI) class, working by irreversibly blocking the hydrogen-potassium ATPase enzyme system in gastric parietal cells [1]. This mechanism reduces stomach acid secretion by up to 95%, providing sustained relief from acid reflux symptoms and allowing damaged oesophageal tissue to heal.

While their core mechanism is identical, lansoprazole and omeprazole differ slightly in their chemical structure and pharmacokinetic profiles [2]. Lansoprazole typically reaches peak plasma concentration within 1.5 to 2 hours, whilst omeprazole peaks at approximately 0.5 to 3.5 hours, though both provide 24-hour acid suppression with once-daily dosing [1][2].

Lansoprazole vs Omeprazole: Clinical Effectiveness

Multiple head-to-head clinical trials have demonstrated comparable efficacy between lansoprazole 30mg and omeprazole 20mg for treating erosive oesophagitis and GORD symptoms [3]. In a large multicentre study, healing rates after eight weeks of treatment were 92% for lansoprazole and 89% for omeprazole, a difference that was not statistically significant.

For symptom relief, both medications typically provide noticeable improvement within 2-3 days, with complete healing of oesophageal erosions occurring over 4-8 weeks in most patients [3]. Some studies suggest lansoprazole may offer slightly faster symptom resolution in the first few days of treatment, though long-term outcomes remain equivalent [2][3].

Dosing Considerations

Standard dosing for acid reflux is lansoprazole 15-30mg once daily or omeprazole 10-20mg once daily, taken before breakfast [1]. Your UK prescriber will determine the appropriate dose based on your symptom severity, medical history, and response to previous treatments. Both medications are available in multiple strengths at Cured Pharmacy, allowing for flexible dose adjustment under clinical supervision.

Side Effects and Tolerability Profile

The side effect profiles of lansoprazole and omeprazole are remarkably similar, with most patients tolerating both medications well [4]. Common side effects include headache (affecting approximately 2-5% of patients), nausea, diarrhoea, abdominal pain, and constipation. These effects are generally mild and resolve without discontinuing treatment.

Long-term PPI use carries similar risks for both medications, including potential vitamin B12 and magnesium deficiency, slightly increased fracture risk, and rare cases of Clostridium difficile infection [4]. The MHRA recommends using the lowest effective dose for the shortest duration necessary, and our UK prescribers regularly review your treatment to ensure continued appropriateness.

Drug Interactions and Special Considerations

Both lansoprazole and omeprazole are metabolised primarily by the cytochrome P450 enzyme system, particularly CYP2C19 and CYP3A4 [5]. This creates potential interactions with medications including clopidogrel, warfarin, certain antifungals, and some antiretroviral drugs. Omeprazole shows slightly stronger CYP2C19 inhibition, which may be clinically relevant if you're taking clopidogrel for cardiovascular protection [5].

Genetic variations in CYP2C19 metabolism affect approximately 15-20% of the UK population, potentially altering how quickly your body processes these medications [5]. Individuals who are 'poor metabolisers' may experience higher drug levels and increased efficacy, whilst 'rapid metabolisers' may require dose adjustments. Your prescriber will consider your medication history and any known drug interactions during your clinical assessment.

Pregnancy and Breastfeeding

Omeprazole has more extensive safety data in pregnancy and is generally preferred when PPI therapy is essential during pregnancy, though both medications are considered relatively safe [4]. Neither lansoprazole nor omeprazole is known to cause harm during breastfeeding, as only small amounts pass into breast milk. Always inform your UK prescriber if you are pregnant, planning pregnancy, or breastfeeding.

Cost and Availability at Cured Pharmacy

At Cured Pharmacy, omeprazole capsules start from £9.99, making it one of the most cost-effective PPI options available in the UK. Lansoprazole capsules are available from £9.99, with both medications requiring a brief online consultation with our UK-registered prescribers before dispensing.

We also stock branded alternatives including Losec (omeprazole) from £9.99 and Zoton FasTab (lansoprazole) from £9.99 for patients who prefer branded formulations. All prices are transparent and displayed upfront, with no hidden consultation fees. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) ensures every prescription meets MHRA standards for safety and quality.

Which PPI Should You Choose?

For most patients with acid reflux, the choice between lansoprazole vs omeprazole UK comes down to individual response, tolerability, and any specific drug interactions [6]. Clinical evidence shows equivalent long-term outcomes, so if you've tried one PPI without adequate symptom control, switching to the other may be worth discussing with your prescriber.

Our UK clinical team at Cured Pharmacy will assess your symptoms, medical history, current medications, and previous treatment responses during your free online consultation. This personalised approach ensures you receive the most appropriate PPI for your individual circumstances, with ongoing support and prescription reviews as needed.

When to Seek Further Medical Advice

If your acid reflux symptoms persist despite 4-8 weeks of PPI therapy, or if you experience alarm symptoms such as difficulty swallowing, unintentional weight loss, persistent vomiting, or black tarry stools, contact your GP or prescriber immediately [6]. These symptoms may indicate complications requiring endoscopic investigation or alternative treatment approaches beyond standard PPI therapy.

Scientific References

1. Stedman, C. A., & Barclay, M. L. (2000). Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics, 14(8), 963-978. https://doi.org/10.1046/j.1365-2036.2000.00788.x
2. Kirchheiner, J., Glatt, S., Fuhr, U., Klotz, U., Meineke, I., Seufferlein, T., & Brockmöller, J. (2009). Relative potency of proton-pump inhibitors—comparison of effects on intragastric pH. European Journal of Clinical Pharmacology, 65(1), 19-31. https://doi.org/10.1007/s00228-008-0576-5
3. Hatlebakk, J. G., Katz, P. O., Kuo, B., & Castell, D. O. (2000). Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily. Alimentary Pharmacology & Therapeutics, 14(12), 1595-1603. https://doi.org/10.1046/j.1365-2036.2000.00867.x
4. Medicines and Healthcare products Regulatory Agency. (2012). Proton pump inhibitors in long-term use: reports of hypomagnesaemia. Drug Safety Update, 5(11), A1. https://www.gov.uk/drug-safety-update/proton-pump-inhibitors-in-long-term-use-reports-of-hypomagnesaemia
5. Li, X. Q., Andersson, T. B., Ahlström, M., & Weidolf, L. (2004). Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities. Drug Metabolism and Disposition, 32(8), 821-827. https://doi.org/10.1124/dmd.32.8.821
6. National Institute for Health and Care Excellence. (2023). Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management (Clinical guideline CG184). https://www.nice.org.uk/guidance/cg184

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.